SCHEDULE: Danone Shifts Lifeway Strategy, Plans Share Sale

Danone S.A. and Danone North America PBC have entered into an agreement with Lifeway Foods, Inc. to facilitate the potential sale of their 22.7% stake and implement corporate governance changes.

Summary

• Danone S.A. and Danone North America PBC (collectively "Danone") hold 3,454,756 shares of Lifeway Foods, Inc. common stock, representing 22.7% of the outstanding shares as of August 6, 2025.
• Danone is no longer interested in acquiring Lifeway and is reviewing its investment, including whether to sell any or all of its shares.
• On September 30, 2025, Danone North America PBC entered into a Letter Agreement with Lifeway to facilitate the potential sale of Danone's shares and implement corporate governance reforms.
• The agreement requires Lifeway to file a shelf registration statement to enable Danone's share sale.
• Lifeway will add three new independent directors within 30 days and a fourth within 45 days, all acceptable to Danone North America PBC.
• Lifeway will appoint an independent chair of its Board of Directors.
• Danone North America PBC will vote in favor of the Lifeway Board at the 2025 and 2026 annual meetings and will not support Edward Smolyansky's solicitation to replace the Board.
• Both parties will jointly seek to stay pending litigation filed in March 2025.
• Lifeway will comply with the existing Stockholders' Agreement, and both parties have mutual non-disparagement obligations.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the resolution of disputes and governance improvements are positive, Danone's explicit disinterest in acquisition and potential large share sale introduce significant uncertainty and potential downward pressure on Lifeway's stock.

Positives

• Resolution of ongoing disputes between Danone and Lifeway through a formal Letter Agreement.
• Commitment to enhance corporate governance at Lifeway with the addition of four new independent directors and an independent Board chair.
• Danone gains "additional optionality" to manage its investment, potentially through an orderly sale of its significant stake.
• The agreement includes mutual non-disparagement obligations, which could lead to a more constructive relationship between the parties.
• The joint effort to stay pending litigation could reduce legal costs and uncertainty for both companies.

Negatives

• Danone has explicitly stated it is no longer interested in pursuing an acquisition of Lifeway, removing a potential upside catalyst for Lifeway shareholders.
• The potential sale of Danone's 22.7% stake (3,454,756 shares) could create selling pressure on Lifeway's stock.
• The ongoing review of Danone's investment creates uncertainty regarding the future ownership structure of Lifeway.
• The filing highlights a past dispute regarding shares purportedly issued to Julie Smolyansky or her spouse without Danone North America PBC's consent, indicating potential historical governance issues.

Risks

• Share Price Volatility: The potential sale of Danone's 22.7% stake could lead to significant downward pressure on Lifeway's stock price.
• Litigation Risk: While parties will seek to stay pending litigation, the underlying disputes could resurface if the Letter Agreement is breached or if a stay is not granted.
• Governance Implementation Risk: Failure by Lifeway to appoint the agreed-upon independent directors or an independent chair could lead to further conflict and termination of Danone's obligations under the Letter Agreement.
• Strategic Uncertainty: Danone's explicit statement of no longer pursuing an acquisition and its intent to review its investment creates uncertainty about Lifeway's long-term strategic direction and potential for future M&A.
• Share Validity Dispute: The reporting persons do not concede the validity of all outstanding shares, specifically mentioning shares purportedly issued to Julie Smolyansky or her spouse without Danone North America PBC's consent, which could imply future legal challenges or disputes over share ownership.

Future Outlook

Danone is continuing to review its investment in Lifeway, including the potential sale of all or part of its 22.7% stake. Danone has explicitly stated it is no longer interested in acquiring Lifeway. The Letter Agreement provides Danone with additional flexibility regarding its investment.

Management Comments

• "Danone North America PBC and Danone S.A. are continuing to review our investment in Lifeway, including whether to sell any or all of the shares of Lifeway Common Stock that we own."
• "As we have previously disclosed, we are no longer interested in pursuing an acquisition of Lifeway."
• "The Letter Agreement will provide us with additional optionality with respect to our ability to sell our shares of Lifeway Common Stock."
• "We may in the future take such actions with respect to our investment in Lifeway as we deem appropriate, including, without limitation, selling all or part of our investment in Lifeway, continuing to hold our investment in Lifeway or changing our intention with respect to any and all matters referred to in Item 4 of Schedule 13D."

Industry Context

This filing reflects a significant strategic shift by a major institutional investor (Danone) in a publicly traded food company (Lifeway Foods). While not directly tied to broader industry trends, it highlights the dynamics of large shareholder activism and divestment strategies within the consumer packaged goods sector, particularly concerning minority stakes and corporate governance disputes.

Management Changes

Corporate Governance

Legal Proceedings

• Pending litigation between Danone North America PBC and Lifeway Foods, Inc., filed in March 2025, which the parties will jointly seek to stay.
• A dispute regarding the validity of certain outstanding shares, specifically those purportedly issued to Julie Smolyansky or her spouse without the consent of Danone North America PBC.

Related Party Transactions

• The existing Stockholders' Agreement between Danone North America PBC and Lifeway Foods, Inc., which Lifeway has agreed to comply with.

Stakeholder Impact

• Shareholders: Potential for increased share price volatility due to Danone's potential divestment of its 22.7% stake. Enhanced corporate governance through new independent directors and an independent chair could improve long-term shareholder value.
• Management: The addition of new independent directors and an independent chair will alter the board's composition and leadership structure, potentially influencing strategic decisions and oversight.
• Employees: No direct impact mentioned, but strategic shifts and governance changes can indirectly affect company culture and direction.

Next Steps

• Lifeway Foods, Inc. to file and maintain a shelf registration statement with the SEC.
• Lifeway Foods, Inc. to add three new independent directors within 30 days of September 30, 2025.
• Lifeway Foods, Inc. to add a fourth new independent director within 45 days of September 30, 2025.
• Lifeway Foods, Inc. to appoint an independent chair of its Board of Directors.
• Danone North America PBC and Lifeway Foods, Inc. will jointly seek to stay pending litigation filed in March 2025.
• Danone S.A. and Danone North America PBC may sell all or part of their investment in Lifeway, continue to hold it, or change their intentions.

Key Dates

Recommendation

The filing indicates a significant strategic shift by a major shareholder, Danone, which is no longer pursuing an acquisition of Lifeway and intends to review the sale of its 22.7% stake. While the Letter Agreement resolves immediate disputes and introduces positive corporate governance changes (new independent directors, independent chair), the potential for a large block sale creates an overhang and uncertainty for Lifeway's stock. Investors should hold to observe the execution of the share sale and the impact of the new governance structure before making further investment decisions.

Keywords

Lifeway Foods, Danone, Schedule 13D, Shareholder Agreement, Corporate Governance, Independent Directors, Share Sale, Investment Review, Litigation, Strategic Shift, Beneficial Ownership